Hepatamin, Epifamin and Suprenamin in competitive rowers
L. R. Emirova, E. A. Rozhkova, V. V. Panyushkin, R. S. Mirzoyan, N. R. Seyfulla · 2004 · Experimental and Clinical Pharmacology 67(3):66–68; same-author dissertation, ergometer Figure 2
Indexed 2026-11-09.
Related evidence maps: Sports performance ↗
Reported findings and study design
Largest reported ergometer gain was 3.94% with ecdysten plus Hepatamin. The journal and thesis describe overlapping work.
Three-week training period with oral cytamins, combinations and comparators. Rowing-ergometer output, estimated body composition and adrenal measures.
Dose, route and schedule
Hepatamin, Epifamin or Suprenamin 20 mg orally three times daily as reported. Separate Apilak, ecdysten, Vitamax and Essentiale arms and combinations.
Protocol source ↗ · Original journal PDF and same-author dissertation, methods and ergometer results
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Highest reported ergometer gain | 3.94% after three weeks | Ecdysten plus Hepatamin; relative change from baseline. |
| Increment versus corresponding comparator | Significant for Hepatamin + Apilak and Hepatamin + ecdysten | Authors reported p<0.05. Other combinations did not show a verified additional performance gain. |
| Dissertation reuse | 120 in the overall rower series | Multiple outcome tables and the journal report do not add independent cohorts. |
Small arms, several interventions and endpoints. Ergometer results cannot establish competitive race-time improvements.
Source for the extracted data ↗ · Checked 2026-11-09
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Small arms, several interventions and endpoints. Ergometer results cannot establish competitive race-time improvements.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original journal PDF and same-author dissertation, methods and ergometer results
Review depth: Reported methods, results and evidence limitations
Related-report group: emirova-rower-program-2004. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original journal PDF and same-author dissertation, methods and ergometer results
Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.
Source type: Experimental and Clinical Pharmacology 67(3):66–68; same-author dissertation, ergometer Figure 2
Citation and original source
Original source: L. R. Emirova, E. A. Rozhkova, V. V. Panyushkin, R. S. Mirzoyan, N. R. Seyfulla. Hepatamin, Epifamin and Suprenamin in competitive rowers Experimental and Clinical Pharmacology 67(3):66–68; same-author dissertation, ergometer Figure 2 2004.
Molekul research summary: https://molekul.io/research/emirova-cytamins-rowers-2004. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Hepatamin
An organ-derived cytamin tested alone and with other agents in a Russian rowing program. The combined-arm result cannot be assigned to Hepatamin alone.
Epifamin
A pineal cytamin studied in rowers. Epithalamin, Pineamin, Pinealon and Epitalon are separate catalogue entries.
Suprenamin
An adrenal-derived cytamin tested alone and in multi-ingredient arms in the Emirova rowing research.